Terminology Service for NFDI4Health
All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| N-tetracosanoylphytosphingosine | CHEBI_52979 | [A phytoceramide compound having a tetracosanoyl group attached to the nitrogen atom.] |
| cyclic tetrapyrrole | CHEBI_36309 | |
| Ins-1-P-Cer(t18:0/26:0)(1-) | CHEBI_65155 | [An inositol phosphophytoceramide(1-) having a hexacosanoyl group attached to the ceramide nitrogen. Major species at pH 7.3.] |
| N-hexacosanoylphytosphingosine | CHEBI_52980 | [A phytoceramide compound having a hexacosanoyl group attached to the nitrogen atom.] |
| Ins-1-P-Cer(t18:0/2-OH-24:0)(1-) | CHEBI_65162 | [An inositol phosphophytoceramide(1-) having a tetracosanoyl group attached to the ceramide nitrogen, hydroxylation at C-4 of the long-chain base, and hydroxylation at C-2 of the very-long-chain fatty acid.] |
| N-(2-hydroxytetracosanoyl)phytosphingosine | CHEBI_52373 | |
| Ins-1-P-Cer(t18:0/2,3-OH-24:0)(1-) | CHEBI_65166 | [An inositol phosphophytoceramide(1-) having a tetracosanoyl group attached to the ceramide nitrogen, hydroxylation at C-4 of the long-chain base, and hydroxylation at C-2 and C-3 of the very-long-chain fatty acid. Major species at pH 7.3.] |
| Ins-1-P-Cer(t18:0/2,3-OH-26:0)(1-) | CHEBI_65168 | [An inositol phosphophytoceramide(1-) having a hexacosanoyl group attached to the ceramide nitrogen, hydroxylation at C-4 of the long-chain base, and hydroxylation at C-2 and C-3 of the very-long-chain fatty acid.] |
| Man-beta1-2-Ins-1-P-Cer(d18:0/24:0)(1-) | CHEBI_65156 | [A mannosylinositol phosphorylceramide(1-) having a tetracosanoyl group attached to the ceramide nitrogen, with no hydroxylation at C-4 of the long-chain base or on the very-long-chain fatty acid.] |
| Ins-1-P-Cer(d18:0/24:0) | CHEBI_60402 | [A ceramide phosphoinositol compound having a tetracosanoyl group attached to the ceramide nitrogen.] |
| momordicoside T | CHEBI_145189 | |
| tranquilizing drug | CHEBI_35473 | [A traditional grouping of drugs said to have a soothing or calming effect on mood, thought or behaviour.] |
| antipsychotic agent | CHEBI_35476 | [Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.] |
| 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion | CHEBI_145186 | |
| lithium salt | CHEBI_35478 | |
| lithium molecular entity | CHEBI_33298 | |
| 1-O-(9Z-octadecenyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion | CHEBI_145188 | |
| 1-O-(1Z-hexadecenyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion | CHEBI_145181 | |
| 1-O-(1Z-octadecenyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion | CHEBI_145182 | |
| 1-O-(1Z,9Z-octadecadienyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion | CHEBI_145183 |